Image default
Amazing Health

Scientists Claim To Have Discovered The Cure Of Hepatitis B

 According to some Australian scientists, a combination therapy of an antiviral drug and an anti-cancer drug has been found 100 percent successful in eliminating the hepatitis B virus (HBV) infections in pre-clinical models.

Hepatitis B is a chronic viral disease that is currently incurable. The virus infects liver cells and can lead to complications including cirrhosis and liver cancer, resulting in more than 780,000 deaths worldwide annually, the study pointed out.

Scientists from Melbourne’s Walter and Eliza Hall Institute developed the combination treatment using birinapant, a drug developed by US biotech company TetraLogic Pharmaceuticals for treating cancer.

An IANS report quoted Marc Pellegrini, one of the researchers, saying, “We were 100 percent successful in curing HBV infection in hundreds of tests in preclinical models.”

 “Birinapant enabled the destruction of hepatitis B-infected liver cells while leaving normal cells unharmed,” Pellegrini added.

“Excitingly, when birinapant was administered in combination with current antiviral drug entecavir, the infection was cleared twice as fast compared with birinapant alone. We are hopeful these promising results will be as successful in human clinical trials, which are currently underway in Melbourne, Perth and Adelaide,” Pellegrini said.

The combination treatment, developed in collaboration with TetraLogic Pharmaceuticals based in Malvern, Pennsylvania, US, targets the cell signalling pathways that the hepatitis B virus uses to keep host liver cells alive.

Chronic infectious diseases such as HBV live within the host’s cells, enabling them to persist within the body for many months or years, Pellegrini said.

“The virus relies on the survival mechanisms of the host, so if it cannot exploit them, it dies. Such a monumental change in the virus’ environment may be too big a hurdle for it to adapt to,” Pellegrini said.

More than two billion people worldwide are infected with hepatitis B and approximately 400 million have a chronic HBV infection.

The findings were detailed in the journal Proceedings of the National Academy of Sciences.

Dear TNT Reader,

At The News Tribe, our mission is to bring you free, independent, and unbiased news and content that keeps you informed and empowered. We are committed to upholding the highest standards of journalism, as we understand that we are a platform for truth.

Apart from independent global news coverage, we also commit our unique focus on the Muslim world. In an age marked by the troubling rise of Islamophobia and widespread misrepresentation of Muslims in Western media, we strive to provide accurate and fair coverage.

But to continue doing so, we need your support. Even a small donation of 1$ can make a big difference. Your contribution will help us maintain the quality of our news and counteract the negative narratives that are so prevalent.

Please consider donating today to ensure we can keep delivering the news that matters. Together, we can make a positive impact on the world, and work towards a more inclusive, informed global society.

Monthly Subscription Annual Subscription

Visa Card MasterCard American Express Card

We want to hear your Travel Stories.

Do you have a memorable, unbelievable, or favorite travel experience? Share your story with us.